Case Study: a leading biopharmaceutical company achieves global post-merger integration success with LEK Consulting

A leading biopharmaceutical company achieves seamless post-merger integration with LEK Consulting, protecting revenues and exceeding synergy targets

L.E.K. Consulting was engaged by a leading biopharmaceutical company to support its transformative acquisition of a similarly sized drug technologies company. The challenge involved a complex post-merger integration, requiring first the separation of the target from its global parent company. The U.S.-centric client needed to maintain business stability upon the transaction's close and then successfully integrate the operations to become a global entity and achieve its synergy targets.

The solution from L.E.K. Consulting included mobilizing integration teams and establishing an integration management office. They supported a detailed transition service agreement for a cleaner separation and helped develop functional integration plans across HR, IT, R&D, and supply chain, among others. The results were highly successful: synergy realization is expected to exceed initial targets, there were no supply interruptions, and back-office operations ran smoothly. L.E.K. Consulting also helped R&D and IT develop long-term organizational plans to support the combined company's strategy.